Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.

French, Juliet D; Johnatty, Sharon E; Lu, Yi; Beesley, Jonathan; Gao, Bo; Kalimutho, Murugan; Henderson, Michelle J; Russell, Amanda J; Kar, Siddhartha; Chen, Xiaoqing; Hillman, Kristine M; Kaufmann, Susanne; Sivakumaran, Haran; O'Reilly, Martin; Wang, Chen; Korbie, Darren J; Lambrechts, Diether; Despierre, Evelyn; Van Nieuwenhuysen, Els; Lambrechts, Sandrina; Vergote, Ignace; Karlan, Beth; Lester, Jenny; Orsulic, Sandra; Walsh, Christine; Fasching, Peter A; Beckmann, Matthias W; Ekici, Arif B; Hein, Alexander; Matsuo, Keitaro; Hosono, Satoyo; Pisterer, Jacobus; Hillemanns, Peter; Nakanishi, Toru; Yatabe, Yasushi; Goodman, Marc T; Lurie, Galina; Matsuno, Rayna K; Thompson, Pamela J; Pejovic, Tanja; Bean, Yukie; Heitz, Florian; Harter, Philipp; du Bois, Andreas; Schwaab, Ira; Hogdall, Estrid; Kjaer, Susanne K; Jensen, Allan; Hogdall, Claus; Lundvall, Lene

French, Juliet D; Johnatty, Sharon E; Lu, Yi; Beesley, Jonathan; Gao, Bo; Kalimutho, Murugan; Henderson, Michelle J; Russell, Amanda J; Kar, Siddhartha; Chen, Xiaoqing; Hillman, Kristine M; Kaufmann, Susanne; Sivakumaran, Haran; O'Reilly, Martin; Wang, Chen; Korbie, Darren J; Lambrechts, Diether; Despierre, Evelyn; Van Nieuwenhuysen, Els; Lambrechts, Sandrina; Vergote, Ignace; Karlan, Beth; Lester, Jenny; Orsulic, Sandra; Walsh, Christine; Fasching, Peter A; Beckmann, Matthias W; Ekici, Arif B; Hein, Alexander; Matsuo, Keitaro; Hosono, Satoyo; Pisterer, Jacobus; Hillemanns, Peter; Nakanishi, Toru; Yatabe, Yasushi; Goodman, Marc T; Lurie, Galina; Matsuno, Rayna K; Thompson, Pamela J; Pejovic, Tanja; Bean, Yukie; Heitz, Florian; Harter, Philipp; du Bois, Andreas; Schwaab, Ira; Hogdall, Estrid; Kjaer, Susanne K; Jensen, Allan; Hogdall, Claus; Lundvall, Lene.

Afiliação

French JD; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Johnatty SE; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Lu Y; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Beesley J; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Gao B; Department of Gynaecological Oncology and Centre for Cancer Research, The Westmead Institute for Medical Research, The University of Sydney, Westmead Hospital, Sydney, Australia.
Kalimutho M; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Henderson MJ; Children's Cancer Institute Australia, Randwick, Australia.
Russell AJ; Children's Cancer Institute Australia, Randwick, Australia.
Kar S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Chen X; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Hillman KM; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Kaufmann S; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Sivakumaran H; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
O'Reilly M; Cancer Research UK Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK.
Wang C; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
Korbie DJ; Australian Institute for Bioengineering and Nanotechnology, University of Queensland, Brisbane, Australia.
Lambrechts D; Vesalius Research Center, VIB, Leuven, Belgium and Laboratory for Translational Genetics, Department of Oncology, University of Leuven, Leuven, Belgium.
Despierre E; Gynecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Van Nieuwenhuysen E; Gynecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Lambrechts S; Gynecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Vergote I; Gynecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Karlan B; Gynecologic Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Lester J; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Orsulic S; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Walsh C; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Fasching PA; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Beckmann MW; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany.
Ekici AB; Department of Medicine, Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Hein A; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany.
Matsuo K; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Hosono S; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-Nuremberg, Erlangen, Germany.
Pisterer J; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
Hillemanns P; Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
Nakanishi T; Zentrum für Gynäkologische Onkologie, Kiel, Germany.
Yatabe Y; Departments of Obstetrics and Gynaecology, Hannover Medical School, Hannover, Germany.
Goodman MT; Department of Gynecology, Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan.
Lurie G; Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan.
Matsuno RK; Cancer Prevention and Control Program, Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Thompson PJ; Cancer Epidemiology Program, University of Hawaii Cancer Center, Hawaii, USA.
Pejovic T; Cancer Epidemiology Program, University of Hawaii Cancer Center, Hawaii, USA.
Bean Y; Cancer Prevention and Control Program, Samuel Oschin Comprehensive Cancer Institute, Cedars Sinai Medical Center, Los Angeles, CA, USA.
Heitz F; Department of Obstetrics and Gynecology, Oregon Health and Science University and Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Harter P; Department of Obstetrics and Gynecology, Oregon Health and Science University and Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
du Bois A; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Schwaab I; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
Hogdall E; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Kjaer SK; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
Jensen A; Department of Gynecology and Gynecologic Oncology, Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Hogdall C; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany.
Lundvall L; Institut für Humangenetik Wiesbaden, Germany.

Oncotarget ; 7(6): 6353-68, 2016 Feb 09.

Article em En | MEDLINE | ID: mdl-26840454

Assuntos

Proteínas Adaptadoras de Transdução de Sinal/genética; Elementos Facilitadores Genéticos/genética; Neoplasias das Tubas Uterinas/mortalidade; Mutação em Linhagem Germinativa/genética; Neoplasias Ovarianas/mortalidade; Neoplasias Peritoneais/mortalidade; Polimorfismo de Nucleotídeo Único/genética; Fatores de Transcrição/genética; Apoptose; Biomarcadores Tumorais/genética; Proliferação de Células; Imunoprecipitação da Cromatina; Estudos de Coortes; Cistadenocarcinoma Seroso/tratamento farmacológico; Cistadenocarcinoma Seroso/genética; Cistadenocarcinoma Seroso/mortalidade; Cistadenocarcinoma Seroso/patologia; Ensaio de Desvio de Mobilidade Eletroforética; Neoplasias das Tubas Uterinas/tratamento farmacológico; Neoplasias das Tubas Uterinas/genética; Neoplasias das Tubas Uterinas/patologia; Feminino; Seguimentos; Humanos; Neoplasias Ovarianas/tratamento farmacológico; Neoplasias Ovarianas/genética; Neoplasias Ovarianas/patologia; Neoplasias Peritoneais/tratamento farmacológico; Neoplasias Peritoneais/genética; Neoplasias Peritoneais/patologia; Prognóstico; RNA Mensageiro/genética; Reação em Cadeia da Polimerase em Tempo Real; Reação em Cadeia da Polimerase Via Transcriptase Reversa; Taxa de Sobrevida; Células Tumorais Cultivadas

Palavras-chave

PSIP1; chromosome conformation capture; epithelial ovarian cancer; genome-wide association study; progression free survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Fatores de Transcrição / Elementos Facilitadores Genéticos / Mutação em Linhagem Germinativa / Polimorfismo de Nucleotídeo Único / Proteínas Adaptadoras de Transdução de Sinal / Neoplasias das Tubas Uterinas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google